Iqvia Holdings Inc (IQV) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iqvia Holdings Inc   (NYSE: IQV)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Iqvia Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Iqvia Holdings Inc's ROI in the second quarter of 2026?
Iqvia Holdings Inc achieved a return on average invested assets (ROI) of 6.03 % in its second quarter of 2026, which is below Iqvia Holdings Inc's average return on investment, which stands at 7.53%.

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 146 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 873 to 1368.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 6.88 % 13.76 % 14.5 % 9.28 % 7.46 %
Y / Y Net Income Change TTM 11.32 % 3.97 % 25.44 % 98.15 % 240.77 %
Investment (TTM) in Millions 21,196 23,735 23,851 22,507 23,191
Return On Investment (TTM) 6.03 % 5.95 % 5.94 % 5.85 % 5.79 %
IQV's Overall Ranking # 1368 # 873 # 1092 # 1033 #
Seq. Investment Change TTM -2.14 % 1.79 % 4.46 % 2.72 % 4.16 %
Seq. Net Income Change TTM -0.72 % 1.91 % 6 % 3.8 % -7.27 %
Net Income (TTM) in Millions 1,377 1,387 1,361 1,284 1,237

IQV Company Profile >> Back to IQV Roi Comparisons >> See Annual IQV Return On Investment



Return On Investment IQV's Ranking
Within: No.
Industry # 9
Sector # 147
Overall # 1368

Return On Investment Statistics
High Average Low
20.89 %
7.53 %
0.38 %
(Dec 31 2014)   (Sep 30 2017)







Financial Statements
Iqvia Holdings Inc's II. Quarter Investments $ 21,196 Millions IQV's Balance sheet
Iqvia Holdings Inc's II. Quarter Income $ 256 Millions Quarterly IQV's Income Statement
IQV's Income by Division See IQV's Income by Division


IQV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 21,733 19,942 20,190 19,759 19,448
Y / Y Investment Growth 8.98 % -1.23 % 2.18 % 1.6 % -4.13 %
Net Income in Millions 1,361 1,373 1,358 1,091 971
Y / Y Net Income Growth -0.87 % 1.1 % 24.47 % 12.36 % 215.26 %
Annual Return On Investment 6.26 % 6.88 % 6.73 % 5.52 % 4.99 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 6.26 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IQV's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IQV's Competitors
Subscribers only: Roi for Iqvia Holdings Inc's Suppliers
Subscribers only: Return On Investment for IQV's Customers

Other Ratios
IQV's Roa IQV's Inventory Turnover Ratio IQV's Growth Rates IQV's Dividend Statistics
IQV's Profitability Ratios IQV's Asset Turnover Ratio IQV's Dividend Growth
IQV's Roe IQV's Valuation Ratios IQV's Financial Strength Ratios IQV's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %

Date modified: 2026-10-23T19:56:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.